Analyst Price Target is $3.42
▲ +560.23% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Eloxx Pharmaceuticals in the last 3 months. The average price target is $3.42, with a high forecast of $5.00 and a low forecast of $1.00. The average price target represents a 560.23% upside from the last price of $0.52.
Current Consensus is
The current consensus among 5 investment analysts is to buy stock in Eloxx Pharmaceuticals. This rating has held steady since May 2021, when it changed from a Hold consensus rating.